Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|March 3, 2020
Sedimentation Velocity Analytical Ultracentrifugation of Oxidized Recombinant Full-Length Factor VIIIPhilip M Zakas, John F Healey, Ian W Smith, et al.
The Journal of Biological Chemistry|December 9, 2003
Identification of porcine coagulation factor VIII domains responsible for high level expression via enhanced secretionChristopher B Doering, John F Healey, Ernest T Parker, et al.
Blood|May 23, 2008
Nonclassical anti-C2 domain antibodies are present in patients with factor VIII inhibitorsShannon L Meeks, John F Healey, Ernest T Parker, et al.
Blood|January 26, 2013
The diversity of the immune response to the A2 domain of human factor VIIIRebecca C Markovitz, John F Healey, Ernest T Parker, et al.
Blood|April 10, 2004
Reduction of the inhibitory antibody response to human factor VIII in hemophilia A mice by mutagenesis of the A2 domain B-cell epitopeErnest T Parker, John F Healey, Rachel T Barrow, et al.
The Journal of Biological Chemistry|July 26, 2002
High level expression of recombinant porcine coagulation factor VIIIChristopher B Doering, John F Healey, Ernest T Parker, et al.
Blood|January 10, 2002
Use of blood outgrowth endothelial cells for gene therapy for hemophilia AYi Lin, Liming Chang, Anna Solovey, et al.
Blood|September 13, 2007
Antihuman factor VIII C2 domain antibodies in hemophilia A mice recognize a functionally complex continuous spectrum of epitopes dominated by inhibitors of factor VIII activationShannon L Meeks, John F Healey, Ernest T Parker, et al.
Thrombosis and Haemostasis|September 28, 2002
Expression and characterization of recombinant murine factor VIIIChristopher Doering, Ernest T Parker, John F Healey, et al.
Thrombosis and Haemostasis|July 3, 2009
The comparative immunogenicity of human and porcine factor VIII in haemophilia A miceJohn F Healey, Ernest T Parker, Rachel T Barrow, et al.
Pageof 3